DOCKING STUDIES ON NOVEL HUMAN CARBONIC ANHYDRASE II
DOI:
https://doi.org/10.7439/ijbar.v2i10.108Abstract
Human Carbonic Anhydrase II (CA II) catalyzes the reversible hydration of carbon dioxide into bicarbonate. The role of CA II in maintaining the fluid and PH balance has made it an attractive drug target for the treatment of Glaucoma. Increased level of intraocular pressure is a major risk factor for development glaucoma disease.Insilico prediction based on the crystal structure of CAII is performed. Active Molecular docking studies using Discovery studio software reveals Diamox is potential inhibitor of CAII and satisfied ADME Properties. The Pass prediction results show the inhibiting activity of CAII enzyme.Downloads
Download data is not yet available.
Downloads
Published
2011-11-08
Issue
Section
Original Research Articles
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeThe Effect of Open Access).
How to Cite
DOCKING STUDIES ON NOVEL HUMAN CARBONIC ANHYDRASE II. (2011). International Journal of Biomedical and Advance Research, 2(10), 410-415. https://doi.org/10.7439/ijbar.v2i10.108
